China Resources Pharmaceutical Group
3320.HK
#2972
Rank
โ‚น364.94 B
Marketcap
โ‚น58.09
Share price
-0.57%
Change (1 day)
14.73%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2022: โ‚น2.831 Trillion

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is โ‚น2.831 Trillion. In 2022 the company made a revenue of โ‚น2.831 Trillion an increase over the revenue in the year 2021 that were of โ‚น2.644 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2013 to 2022

Annual revenue

Year Revenue Change
2022โ‚น2.831 T7.09%
2021โ‚น2.644 T17.47%
2020โ‚น2.250 T-1.52%
2019โ‚น2.285 T8.38%
2018โ‚น2.108 T9.69%
2017โ‚น1.922 T9.28%
2016โ‚น1.759 T6.86%
2015โ‚น1.646 T8.05%
2014โ‚น1.523 T16.04%
2013โ‚น1.313 T